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A helper-dependent expression system based on transmissible gastroenteritis coronavirus (TGEV)
has been developed using a minigenome of 3–9 kb (M39). Expression of the reporter gene b-
glucuronidase (GUS) (2–8 lg per 106 cells) and the porcine respiratory and reproductive syndrome
virus (PRRSV) ORF5 (1–2 lg per 106 cells) has been shown using a TGEV-derived minigenome. GUS
expression levels increased about eightfold with the m.o.i. and were maintained for more than
eight passages in cell culture. Nevertheless, instability of the GUS and ORF5 subgenomic mRNAs
was observed from passages five and four, respectively. About a quarter of the cells in culture
expressing the helper virus also produced the reporter gene as determined by studying GUS mRNA
production by in situ hybridization or immunodetection to visualize the protein synthesized.
Expression of GUS was detected in the lungs, but not in the gut, of swine immunized with the virus
vector. Around a quarter of lung cells showing replication of the helper virus were also positive for
the reporter gene. Interestingly, strong humoral immune responses to both GUS and PRRSV ORF5
were induced in swine with this virus vector. The large cloning capacity and the tissue specificity of
the TGEV-derived minigenomes suggest that these virus vectors are very promising for vaccine
development.
Introduction
Transmissible gastroenteritis virus (TGEV) is a member of
the Coronaviridae family that, with the Arteriviridae, forms the
Nidovirales order (Enjuanes et al., 2000b). The TGEV RNA
genome has a length of 28–5 kb (Penzes et al., 2001). About
two-thirds of the entire RNA comprise the ORF1ab encoding
the replicase gene. The 3« one-third of the genome comprises
the genes encoding the structural and non-structural proteins.
Coronaviruses include a large family of viruses that infect a
broad range of vertebrates, from mammalian to avian species
(Lai & Cavanagh, 1997 ; Siddell, 1995). Coronaviruses are
mainly associated with respiratory, enteric, hepatic and central
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nervous system diseases. Nevertheless, organs such as kidney,
heart and eye can also be affected. In humans and fowl,
coronaviruses primarily cause upper respiratory tract infec-
tions, while porcine and bovine coronaviruses establish enteric
infections that result in severe economic loss (Caul &
Egglestone, 1982 ; Denison, 1999 ; Enjuanes et al., 2001).
Coronaviruses have several advantages as vectors over
other virus expression systems. They are single-stranded (ss)
RNA viruses that essentially replicate within the cytoplasm
without a DNA intermediary, making integration of the virus
genome into a host cell chromosome unlikely (Lai & Cavanagh,
1997). Coronaviruses have the largest RNA virus genome and,
in principle, have room for the insertion of large foreign genes
(Enjuanes et al., 2000a ; Masters, 1999). Since they usually
infect the mucosal surfaces, both respiratory and enteric, they
may be used to target the antigen to the enteric and respira-
tory areas to induce a strong secretory immune response
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(Ballesteros et al., 1997 ; Enjuanes & Van der Zeijst, 1995 ; Kuo
et al., 2000 ; Leparc-Goffart et al., 1998 ; Sa! nchez et al., 1999).
Two types of expression systems have been developed
based on coronavirus genomes (Enjuanes et al., 2001 ; Liao et
al., 1995 ; Zhang et al., 1997). One type, the helper-dependent
expression system, requires two components, and the other
requires a single genome that is modified either by targeted
recombination (Masters, 1999) or by engineering a cDNA
encoding an infectious RNA (Almaza! n et al., 2000 ; Thiel et al.,
2001 ; Yount et al., 2000). The first attempt to use a coronavirus
for heterologous gene expression was based on mouse
hepatitis virus (MHV) by using a helper-dependent expression
system (Liao et al., 1995 ; Zhang et al., 1997). Expression with
MHV has been based on the use of either internal ribosome
entry sites or transcription regulatory sequences (TRSs) present
within the viral genes (Liao et al., 1995 ; Lin & Lai, 1993 ; Zhang
et al., 1997). More recently, helper-dependent expression
systems based on infectious bronchitis virus (IBV) (Stirrups et
al., 2000), human coronavirus HCoV-229E (Thiel et al., 1998)
and bovine coronavirus (Krishnan et al., 1996) have also been
developed.
Helper-dependent expression systems have been designed
based on TGEV-derived minigenomes (Alonso et al., 2002 ;
Izeta et al., 1999). The expression of the reporter gene b-
glucuronidase (GUS) under the control of optimized TRSs has
been shown (Alonso et al., 2002). An improvement introduced
in these systems was a two step amplification system based on
expression of the viral minigenome under the control of the
cytomegalovirus (CMV) early promoter within the nucleus,
coupled to a second amplification step of minigenome RNAs
translocated to the cytoplasm by the viral polymerase (Izeta et
al., 1999), as previously described for other positive-stranded
RNA genomes (Dubensky et al., 1996).
In this report, the expression of GUS and the ORF5
involved in the protection against the porcine reproductive
and respiratory syndrome virus (PRRSV), a virus with a high
impact on animal health (Pirzadeh & Dea, 1998 ; Plana-Dura! n
et al., 1997a, b), has been studied both in tissue culture and in
swine. The protein expression levels, the stability of the vector,
the tissue distribution and the humoral immune response
elicited against the heterologous gene have been analysed. It
has been shown that the TGEV-derived virus vector achieved
high foreign gene expression levels, which led to the induction
of significant immune responses in swine. The stability of
TGEV-derived minigenomes was highly dependent on the
heterologous gene and was significantly increased over
previous systems.
Methods
+ Cells and viruses. The TGEV PUR46-MAD strain (Sa! nchez et al.,
1990) was grown and titrated as described (Jime! nez et al., 1986). Viruses
were grown in swine testis (ST) cells (McClurkin & Norman, 1966).
PRRSV Olot91 strain (Plana-Dura! n et al., 1992) was grown in African
green monkey kidney (MA-104) cells (Meulenberg et al., 1998).
+ Construction of cDNAs encoding RNA minigenomes. The
construction of DI-C-derived cDNA encoding RNA minigenome M39
was previously described (Izeta et al., 1999). To increase minigenome
RNA expression levels, the cDNAs were preceded by the CMV
promoter (Dubensky et al., 1996 ; Penzes et al., 1998). The minigenome
was flanked at the 3« end by the hepatitis delta virus ribozyme and the
bovine growth hormone polyadenylation and termination sequences
(Penzes et al., 1998).
To evaluate expression levels using the minigenomes, E. coli K12 GUS
was used as a reporter gene (Jefferson et al., 1986 ; Schlaman et al., 1994).
The GUS gene was amplified by PCR from plasmid pGUS1 (Plant
Genetic Systems) using a forward 40-mer oligonucleotide (5« GCGGC-
CGCAGGCCTGTCGACGACCATGGTCCGTCCTGTAG 3«) which
included NotI, StuI and SalI restriction endonuclease sites (bold
nucleotides). The GUS initiation codon is underlined. Nucleotides shown
in italics were included to fit the consensus motif of the ribosome
scanning model (Kozak, 1991a, b). The reverse primer was 41 nt long
(5« GGTACCGCGCGCCTGGGCTAGCGCGATCATAGGCGTCT-
CGC 3«) and included KpnI, BssHII and NheI restriction sites (bold
nucleotides). PRRSV Olot91 strain ORF5 (nt 1763–2365 of sequence
deposited in EMBL, accession no. X92942) was amplified by PCR from
plasmid pMTL25-PRRSV-ORF5 using a forward 33-mer oligonucleotide
(5« GGTCGACGACCATGAGATGTTCTCACAAATTGG 3«) and a
29-mer reverse primer (5« GGCTAGCCTAGGCTTCCCATTGCTCA-
GCC 3«) that included the restriction endonuclease sites SalI and NheI
(bold nucleotides), respectively. The consensus motif of the ribosome
scanning model is shown in italics and the translation initiation codon is
underlined.
The expression cassettes encoding the GUS gene and the PRRSV
ORF5 were cloned at position 3337 from the 5« end of minigenome M39
as described by Alonso et al. (2002), generating minigenomes M39-GUS
and M39-ORF5, respectively. To ensure that the expected plasmids were
generated, the constructs were sequenced at the cloning junctions using
an Applied Biosystems 373 DNA sequencer.
+ Rescue of minigenomes encoding the expression cassettes.
ST cells grown to 50% confluence in 35 mm dishes were transfected with
10 lg of plasmid DNA encoding CMV-driven minigenomes and 15 ll of
Lipofectin reagent in Optimem medium (Gibco-BRL), according to the
manufacturer’s instructions. The transfected cells were infected with
TGEV PUR46-MAD (m.o.i. 5) at 4 h post-transfection. Supernatants
obtained from these cultures at 22–24 h post-infection (p.i.) were used to
infect fresh ST cell monolayers. The indicated number of passages were
performed to amplify the helper virus and minigenome-derived RNAs.
+ RNA analysis by Northern blotting. Total intracellular RNA was
extracted at 16 h p.i. from DNA-transfected and helper virus-infected ST
cells at different passages using the Ultraspec RNA isolation system
(Biotecx), following the manufacturer’s instructions. RNAs were separ-
ated in denaturing 1% agarose, 2–2 M formaldehyde gels. Following
electrophoresis, RNAs were irradiated for 0–2 min using a UVP cross-
linker (CL-1000) and blotted onto nylon membranes (Duralon-UV,
Stratagene) using a Vacugene pump (Pharmacia). The nylon membranes
were irradiated with two pulses of 70 mJ}cm# and hybridized with
[a-$#P]dATP-labelled ssDNA probes following standard procedures
(Sambrook et al., 1989). The 3« UTR-specific ssDNA probe was
complementary to nt 28300–28544 of the TGEV PUR46-MAD strain
genome (Penzes et al., 2001). The GUS- and ORF5-specific probes were
complementary to the first 296 and 276 nt of these genes, respectively.
The membrane was exposed to an X-OMAT Kodak Scientific Imaging
film for 8 h at fi70 °C.
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+ Western blot and immunoprecipitation analysis. GUS ex-
pression in cells transfected with cDNA encoding a minigenome and
infected with helper virus was analysed at passage four by Western blot
as described previously (Alonso et al., 2002). Purified GUS protein
(Sigma) was used as a positive control. A GUS-specific polyclonal rabbit
antibody (5 Prime-3 Prime) diluted 1 :200 in TBS buffer (Tris–HCl
20 mM pH 7–5, NaCl 500 mM) was used as the primary antibody to
detect GUS protein. Rabbit-specific goat-antibody conjugated to per-
oxidase, diluted 1 :8000 in TTBS buffer (TBS with Tween-20, 0–1%), was
used as secondary antibody.
Immunoprecipitation of PRRSV ORF5 was performed as described
(Torres et al., 1995). Briefly, ST cell monolayers grown in 35 mm dishes
were infected with a mixture containing the helper virus (TGEV PUR46-
MAD) and the minigenome encoding PRRSV ORF5 (M39-ORF5). MA-
104 cell monolayers grown in 35 mm dishes infected with PRRSV were
used as a positive control. After 1 h of virus adsorption at 37 °C, fresh
medium was added and cells were incubated for 4 h at 37 °C. Cells were
washed with starvation medium methionine- and cysteine-free, overlaid
with this medium containing 2% foetal calf serum, and incubated for 1 h
at 37 °C. The medium was then replaced by in vitro labelling mix contain-
ing 60 lCi of l-[$&S]methionine}cysteine (Amersham Pharmacia Biotech)
and incubated for 13 h at 37 °C. The cells were detached from the dish
with a rubber policeman, washed with PBS by centrifugation at 3000
r.p.m. for 15 min at 4 °C and lysed in RIPA buffer (Torres et al., 1995).
Antisera used for preclearing and for immunoprecipitation were bound to
protein A–Sepharose beads by overnight incubation at 4 °C. Cell extracts
were precleaned by incubation with a preimmune rabbit antiserum bound
to protein A–Sepharose beads for 3 h at 4 °C. Supernatants were next
immunoprecipitated by overnight incubation at 4 °C with a rabbit
antiserum specific for PRRSV Olot91 strain ORF5, obtained by
immunization with an ORF5-derived synthetic 18 amino acid peptide
(NH
#
-142-TNFIVDDRGRIHRWKSPI-159-COOH), bound to protein
A–Sepharose beads. After four washes in RIPA buffer containing 0–2%
SDS, the pelleted beads were resuspended in SDS sample buffer
containing 2–5% b-mercaptoethanol, boiled for 3 min and centrifuged at
low speed to sediment the beads. The immunoprecipitated proteins were
resolved in an SDS}5–20% polyacrylamide gel. The gel was fixed (10%
acetic acid, 35% ethanol) before incubation with 14% (w}w) sodium
salicylate (Merck) for 30 min at room temperature and finally dried at
80 °C for 1 h and exposed to an X-OMAT Kodak Scientific Imaging film.
+ ELISA. Antibodies generated against GUS and PRRSV ORF5 were
detected by ELISA as described (Ausubel, 1987). ELISA was performed
using as antigen purified TGEV (0–2 lg per well), partially purified
PRRSV (1 :100 dilution of partially purified PRRSV with 3–2‹10%
TCID
&!
}ml), purified GUS protein (Sigma, 0–5 lg per well) or the KLH-
conjugated ORF5 peptide (0–5 lg per well). ORF5 peptide was
conjugated to KLH using the Imject Immunogen EDC conjugation kit
with mcKLH (Pierce) following the manufacturer’s instructions. To
perform the ELISA, antigens were bound to 96-well microplates as
previously described (Correa et al., 1988), saturated with 5% BSA in PBS
for 2 h at 37 °C and incubated with the serum sample diluted 1 :4 in
PBS–0–1% BSA for 3 h at room temperature. Microplates were washed
six times with 0–1% BSA and 0–1% Tween-20 in PBS and sequentially
incubated with peroxidase-conjugated protein A diluted 1 :2000 in PBS
with 0–1% BSA. Microplates were washed six times before incubation
with the peroxidase substrate phenylenediamine dihydrochloride (Sigma
FAST) for 15 min at room temperature. Reactions were stopped with
1–5 M H
#
SO
%
, and the absorbance was read at 492 nm.
+ GUS chemiluminescent detection in cell extracts. GUS
expression in cell extracts was detected by a chemiluminescent assay
(GUS-Light kit, Tropix), according to the manufacturer’s instructions
(Bronstein et al., 1994). Cells transfected with GUS-encoding mini-
genome, or mock-transfected, were infected with helper virus (m.o.i. 5).
The amount of protein expressed 22–24 h p.i. was estimated using
standard calibration curves generated with purified GUS (Sigma) and the
bicinchoninic acid protein assay (BCA, Pierce), resulting in 10’ relative
luminometric units per 0–35 ng of GUS.
+ Analysis of TGEV-infected newborn swine. Conventionally
raised, 2-day-old, colostrum-deprived piglets, serologically negative for
TGEV were inoculated with a mixture containing 10) p.f.u. of helper virus
(TGEV PUR46-MAD) and the minigenome M39-GUS by both oronasal
and enteric tract (using a gastric tube) routes. Three replicate experiments
were performed and clinical signs were recorded during the experiments.
Five piglets were sacrificed on each of the 3 days following inoculation,
subjected to necropsy, and lungs, jejunum and ileum were collected. Two
mock-infected piglets were also sacrificed each day.
For histopathological examination, lung tissue samples (four different
locations) and samples from small and large intestine (five different
locations) were either snap-frozen and stored at fi70 °C until further use
to prepare cryostat sections or immediately fixed in 4% neutral-buffered
formalin and processed for paraffin-embedding, sectioning and haema-
toxylin and eosin staining.
For virus isolation, frozen tissue was thawed and homogenized on ice
in PBS (1 ml}g tissue) with an Ultra-Turrax. After 12 min centrifugation
at 3000 r.p.m., the supernatant was diluted 1 :5 in PBS with antibiotics
and left at 4 °C for 1 h. After spinning for 15 min at 12000 r.p.m., the
supernatant was diluted serially in Dulbecco’s modified Eagle medium
with 2% foetal calf serum, including antibiotics and 40 lg}ml of DEAE-
dextran. Virus was titrated on ST cell monolayers.
For immunofluorescence staining, cryostat sections of intestine and
lungs were fixed with acetone (fi20 °C) for 10 min and incubated for 1 h
at 37 °C with FITC-labelled anti-TGEV hyperimmune serum, diluted
1 :10 in 0–2 M Tris–HCl, pH 8–6 and mixed at a ratio of 3 :1 with 0–005%
Evan’s blue solution. Sections were sealed in glycerol buffer containing
25 mg}ml of 1,4-diazabicyclo(2,2,2)octane (DABCO).
For GUS histochemistry, cryostat sections of intestine and lungs
were fixed for 45 min using the fixation buffer provided with the b-
glucuronidase reporter gene kit (Sigma), according to the manufacturer’s
recommendations. Sections were washed repeatedly with 10 mM sodium
phosphate pH 7–0 and 0–2 mM EDTA and incubated overnight at 37 °C
in the staining solution containing both potassium ferri- and ferrocyanide.
+ In situ hybridization (ISH). For preparation of non-radioactive
riboprobes, in vitro transcription using the digoxigenin RNA labelling
technique was performed as described (Zurbriggen et al., 1998) with
probes complementary to the 3« end of TGEV PUR46-MAD and to the
GUS gene (see above). PCR-amplified DNA was cloned into the pGEM-
T-Easy plasmid vector (Promega). In vitro transcription was performed
with the RiboMAX system to yield digoxigenin-11-dUTP (Roche
Molecular Biochemicals) riboprobes using sense (from SP6 promoter) and
antisense (from T7 promoter) riboprimers. After shortening the probes to
a length of about 150 bases they were stored in diethyl-pyrocarbonate-
treated water at fi70 °C until further use. For ISH, tissue culture chamber
slides and cryostat sections were fixed with 4% paraformaldehyde in PBS.
For permeabilization and proteolytic digestion, proteinase K was applied
to cells (0–1–0–5 lg}ml) and tissues (1–5 lg}ml). Hybridization was
performed overnight at 50 °C using 1–2 ng}ll of the probes. To digest
any unbound probe, the sections were treated with RNase T1 and
DNase-free RNase (Roche). For immunological probe detection, the
sections were incubated for 2 h with an alkaline phosphatase-conjugated
FGJ
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anti-digoxigenin antibody diluted 1 :500 (Roche). Nitro blue tetrazolium
and 5-bromo-4-chloro-4-indolylphosphate were used as substrates for
colour reaction. Overnight development of the dark blue signal was
stopped in TE buffer (pH 8–0).
+ Morphometric analysis of ISH signals on ST cells and lung.
Morphometric analysis and quantification of TGEV-RNA- and GUS-
RNA-positive cells in tissue culture and lung tissues were performed
using the KS300 image analysis system (Zeiss). Calibration and threshold
determination for the staining were done once for each section using
the objective 20‹. For each probe, three hybridization assays were
performed in tissue culture and for each animal four locations of lung
tissue were investigated and 20 randomly selected neighbouring, non-
overlapping fields were measured. The evaluated parameter was TGEV-
RNA- or GUS-RNA-positive area (lm#), expressed as a percentage of the
total area of cells or tissue examined.
+ Immunizations. Groups of 1-week-old swine (derived from
crossing Belgium Landrace and Large White swine) were immunized by
the oronasal and intragastric routes. Piglets were obtained from sows
seronegative for TGEV and PRRSV, as determined by radioimmunoassay
(Sa! nchez et al., 1999) and inmunoperoxidase monolayer assay (Harlow &
Lane, 1988). One-week-old animals were immunized three times at days
7, 14 and 21 after birth, by administering each time three doses : orally
(5–0‹10) p.f.u. per pig), intranasally (5–0‹10) p.f.u. per pig) and
intragastrically (1–5‹10* p.f.u. per pig) of the helper virus (TGEV
PUR46-MAD) and the minigenome M39-GUS or M39-ORF5. Piglets
inoculated with the same minigenome were taken together and housed in
isolation chambers located in a P3-level containment facility at 18–20 °C.
Serum was collected 7 days after the last immunization.
Results
Structure of the helper-dependent expression system
and expression levels
TGEV-derived expression systems have been developed
based on two components, a helper virus (the attenuated strain
PUR46-MAD of TGEV) (Sa! nchez et al., 1999) and a mini-
genome of 3–9 kb (M39) derived from the helper virus (Izeta et
al., 1999). The minigenome was cloned under the control of the
CMV promoter and was amplified first in the nucleus by cell
polymerase II, coupled to a second amplification step of the
translocated minigenome RNAs by the viral RNA-dependent
RNA-polymerase within the cytoplasm. The GUS (mini-
genome M39-GUS) and the PRRSV ORF5 (minigenome M39-
ORF5) genes were inserted at position 3337 from the
minigenome 5« end, within an expression cassette composed of
a TRS including the highly conserved core sequence 5«
CUAAAC 3«, and 10 nt with an optimized Kozak sequence
(L3, 5« GUCGACGACC 3«) (Alonso et al., 2002) (Fig. 1A).
Expression levels were analysed by Western blot (GUS) (Fig.
1B) or by immunoprecipitation (ORF5) (Fig. 1C), using as
positive controls either purified GUS or the viral proteins
expressed in PRRSV-infected cells. In the immunoprecipitation
of ORF5, a second band with the molecular mass expected for
an ORF5 homodimer was also observed. The same type of
second bandwas previously observed by Western blot analysis
of PRRSV proteins (Meulenberg et al., 1995).
Fig. 1. Analysis of the protein expressed by TGEV-derived minigenomes.
(A) Schematic structure of expression modules based on TGEV-derived
minigenome M39 cloned under the control of the cytomegalovirus
immediate early promoter (CMV). The expression cassette is flanked by
L1 and L4 polylinkers. This cassette includes the transcription regulatory
sequence (TRS), an insertion site (L3), an optimized Kozak sequence (K)
and the GUS or the PRRSV ORF5 heterologous genes. HDV, Hepatitis
delta virus ribozyme; BGH, bovine growth hormone termination and
polyadenylation signals. (B) Western blot analysis of GUS expression using
the TGEV-derived minigenome M39-GUS. Detection of the heterologous
protein GUS (69 kDa) was performed under reducing conditions, using a
GUS-specific polyclonal rabbit-antiserum. The molecular mass is indicated
on the left. Purified GUS (Sigma) was used as the positive control. M39-
GUS, cell extracts from ST cells infected with minigenome M39-GUS and
helper virus (PUR46-MAD). M39, Cell extracts from ST cells infected with
minigenome M39 and the helper virus. (C) Detection of PRRSV ORF5
expression using minigenome M39-ORF5 grown in the presence of
[35S]methionine/cysteine. Cell extracts were immunoprecipitated using
rabbit antiserum specific for an ORF5 peptide (see Methods). The
immunoprecipitated proteins were analysed by SDS–PAGE and
autoradiography. Two bands were observed, one with the expected size
for PRRSV ORF5 (25 kDa) and the other that corresponds to a dimer of
this protein. Both bands are indicated by an arrow on the right side of the
panel. The position of molecular mass markers (M) is indicated on the left.
Mock, uninfected MA-104 cells ; PRRSV, MA-104 cells infected with
PRRSV; H›M39, epithelial ST cells infected with the minigenome M39
and the helper virus ; H›M39-ORF5, ST cells infected with the
minigenome M39-ORF5 and the helper virus ; H, helper virus (PUR46-
MAD).
GUS expression levels in different assays were between 2
and 8 lg per 10’ cells. The amount of protein expressed was
determined at 22–24 h p.i. using standard calibration curves
generated with purified GUS (Sigma) and the dicinchoninic
acid protein assay (BCA, Pierce), resulting in 10’ relative
luminometric units per 0–35 ng of GUS. The results were
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Fig. 2. Relationship between m.o.i. of the helper virus and expression
levels of GUS. Confluent ST cell monolayers were inoculated at the
indicated m.o.i. with supernatant from passage four containing the helper
virus (TGEV PUR46-MAD) and the minigenome encoding the GUS gene
(M39-GUS). Cell extracts were used to determine the amount of GUS
protein per 106 cells expressed by the minigenome encoding the GUS
gene. The data shown represent the average of at least three experiments
with the standard error.
Fig. 3. Expression of GUS gene by TGEV-derived minigenomes upon
passage in cell culture. GUS expression per 106 cells generated by
minigenome M39 encoding the GUS gene under the control of an
optimized TRS (M39-GUS) was followed throughout eight passages after
transfection by using a luminometric assay based on the GUS enzymatic
activity. Background levels are those corresponding to the minigenome
M39 without insert. The data show an average of at least three
experiments with similar results. Bars, standard error.
coincident with those obtained by comparing the protein band
intensity obtained by Western blot analysis developed using a
polyclonal rabbit antibody (5 Prime-3 Prime) and known
amounts of purified GUS protein. An internal standard for
ORF5 was not available but, based on band intensity, ORF5
protein expression levels were estimated between 1 and 2 lg
per 10’ cells. GUS expression levels increased more than
eightfold by increasing the m.o.i. from 1 to 20 (Fig. 2), as could
be expected for the amplification of a minigenome that is
dependent on helper virus replication.
Stability of TGEV-derived minigenomes encoding
heterologous genes
GUS expression was studied along different passages of the
helper virus with the minigenome M39-GUS by analysing
GUS enzymatic activity. Expression was optimum for about
five passages and then slowly declined, being about 60-fold
over background at passage eight (Fig. 3). The stability of
minigenome M39-GUS RNA and of the mRNA encoding
GUS was evaluated at passages two and five by Northern blot
using two probes, one complementary to the 3« end of the
genome (Fig. 4A) and another to GUS (Fig. 4B). The 3« end
probe clearly detected all viral mRNA (S, 3a, E, M, N and 7),
but the probe complementary to the GUS gene was more
efficient at visualizing the minigenome including the GUS
gene. Interestingly, at passage two, a clean single band
corresponding to minigenome M39-GUS was observed with
the GUS probe, while at passage five, additional bands of
smaller size appeared, probably due to the generation of
deleted minigenomes. The subgenomic mRNAs (sgmRNAs)
were also identified at passages two and five (Fig. 4B). Similar
results were obtained by expressing GUS using a minigenome
of 5–4 kb (M54) (data not shown). The heterologous GUS gene
was responsible for the instability of the minigenomes, since
TGEV minigenomes of 3–9 and 5–4 kb remained stable for at
least 30 passages, without generating new dominant RNAs, in
the absence of the heterologous gene (Izeta et al., 1999) (data
not shown). Increase in minigenome length from 3–9 to 5–4 kb
did not improve expression levels (data not shown).
Instability in the synthesis of the minigenomes encoding
the ORF5 gene was also observed (Fig. 5). Northern blot
analysis indicated that at passages four and six, in addition to
a minigenome with the expected size for M39-ORF5, other
bands of smaller size were detected with the 3« end probe (Fig.
5A) and more clearly with the probe complementary to ORF5
(Fig. 5B). One of these RNA bands (DM39-ORF5) was more
abundant than the full-length minigenome. Interestingly, bands
with the size expected for the subgenomic mRNA encoding
ORF5 (sgmRNA) and for the deleted minigenome (DsgmRNA)
were also detected. The identity of these bands was assessed
by RNA extraction, amplification by RT–PCR and sequence
analysis (data not shown). The relative abundance of the
sgmRNAs was about 50-fold lower than that of the cor-
responding minigenomes.
Replication of helper virus and minigenome and
expression of GUS in cell culture
The number of cells replicating the helper virus and
expressing the sgmRNA encoding GUS was determined by
ISH using non-radioactive labelled riboprobes complementary
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Fig. 4. Stability of TGEV-derived minigenomes encoding the GUS gene. Northern blot analysis of intracellular RNAs extracted at
passages two (p2) and five (p5) from minigenome transfected and TGEV-infected cells. Hybridization was performed using
probes complementary to the 3« UTR of the genome (A) and to the GUS gene (B). The positions of helper virus mRNAs (S, 3a,
E, M, N, 7) are indicated on the left. The position of minigenome RNA encoding the GUS gene (M39-GUS) is indicated by an
arrow on the right side of the figure. The M39 RNA overlaps with the helper virus mRNA 3a, and its position has been indicated
by an arrow (M39). Mock, uninfected cells ; H, helper virus (PUR46-MAD); M39, minigenome without the heterologous gene.
to the 3« end of the virus and to the GUS gene (Fig. 6). Whereas
47–1‡19–2% of ST cells contained TGEV-RNA (Fig. 6A), a
smaller number of cells, i.e. 12–9‡4–4 %, showed hybridization
signals specific for GUS minigenome RNA (Fig. 6B). The
expression of viral and heterologous antigen proteins was
studied by immunofluorescence and by histochemical detection
using the substrate X-Gluc (5-bromo-4-chloro-3-indolyl-b-d-
glucuronid), which resulted in a Prussian blue staining of cells
with GUS enzymatic activity. At 18 h p.i. TGEV antigen was
demonstrated in large amounts in the cytoplasm of about 40%
of ST cells (Fig. 6C), while GUS activity was detected in about
12% of the cells (Fig. 6D). The number and distribution of
positive cells by ISH was very similar to results obtained by
immunofluorescence and histochemistry. These results indi-
cated that more than one-quarter of the infected cells expressed
a significant amount of the GUS gene encoded within the
minigenome.
In vivo replication of TGEV and expression of GUS
The helper virus carrying the minigenome replicated in
both the gut and the lungs of infected piglets (Fig. 7). At
different days post-infection, virus titres were 40- to 10$-fold
higher in the lungs than in the gut. At day 1 post-inoculation,
titres in the lung and the gut were 4‹10( and 2‹10& p.f.u.}g
of tissue, respectively, and then declined, being around 10$
p.f.u.}g of tissue in both cases at day 4 p.i. (Fig. 7A, B).
Immunofluorescence for TGEV correlated well with infectious
virus isolation in the lungs and in the gut (Fig. 8). It was not
possible to detect GUS protein in other than lung tissues of
infected animals by immunofluorescence or by using the
GUS-Light assay, even in the presence of 2‹10& p.f.u. of
helper virus}g of tissue, suggesting that the helper virus and
the minigenome were not present within the same cell.
TGEV RNA detected by ISH was higher in tissue culture
cells than in vivo. TGEV RNA and protein (determined by
immunofluorescence) were preferentially present in bron-
chiolar epithelial cells and pneumocytes starting at day 1 p.i.
(Fig. 8A, C) and decreased thereafter (data not shown). Lung
tissue area hybridization signals specific for TGEV RNA were
detectable in 4–3‡2–1% of the cells (Fig. 8A), whereas an
overall larger number of pneumocytes (" 20%) displayed
TGEV antigen-specific fluorescence (Fig. 8C). The presence of
a lower number of positive cells for viral RNA than for viral
protein could be due to the shorter half-life of TGEV RNA in
relation to that of the protein. GUS RNA was displayed in
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Fig. 5. Stability of TGEV-derived minigenomes encoding the PRRSV ORF5. Northern blot analysis of intracellular RNAs extracted
at passages four (p4) and six (p6) from minigenome transfected and TGEV-infected ST cells. Hybridization was performed
using probes complementary to the 3« UTR of the genome (A) and to the ORF5 (B). The positions of mRNAs (S, 3a, E, M, N,
7) from the helper virus are indicated on the left. The position of minigenome RNAs encoding full-length (M39-ORF5) or
partially deleted (DM39-ORF5) PRRSV ORF5 and the sgmRNAs synthesized from them (sgmRNA and DsgmRNA, respectively)
are indicated by arrows on the right side of the figure. The M39 RNA overlaps with the helper virus mRNA 3a. Mock, uninfected
cells ; H, helper virus (PUR46-MAD); M39, minigenome without the heterologous gene; its position has been indicated by an
arrow to the right of (A).
1–5‡0–9% of pulmonary tissue (Fig. 8B a, b and c). This
relatively small number of GUS RNA-positive cells was
consistent with findings obtained by histochemical staining
(Fig. 8D a, b and c). More than one-quarter of the cells
expressing the helper virus RNA in the lungs also expressed
minigenome RNA. This fraction of GUS-positive cells in the
lungs is similar to the fraction of ST cells expressing GUS in
cell cultures as reported above.
Pathology and histopathology in swine administered
with the helper virus and the minigenomes expressing
GUS
The replication of TGEV in swine is highest in colostrum-
deprived newborn piglets. This is particularly the case with
attenuated viruses like the TGEV PUR46-MAD strain used in
these studies. In contrast, 2-day-old conventional (non-
colostrum deprived) piglets breast-fed by sows seronegative
for TGEV, or for porcine respiratory coronavirus, inoculated
with the attenuated strain PUR46-MAD show very mild or no
obvious diarrhoea and are completely recovered by day 8 p.i.
(Sa! nchez et al., 1999).
To potentiate minigenome replication by the helper virus,
colostrum-deprived newborn piglets were infected 2 days after
birth. At necropsy 2 days after infection, piglets had the lungs
slightly to moderately collapsed and showed consolidation
and signs of bronchopneumonia especially in the cranioventral
lobes. By histopathology, the lungs showed multifocal neo-
natal atelectasia, massive accumulation of granulocytes in the
alveoli, thickened alveolar septa with slight hyperplasia of type
II pneumocytes, and focal necrosis of the alveolar epithelium.
Only a slight hyperaemia of small intestine vessels was
occasionally seen. In the jejunum there was a slight to marked
diffuse atrophy of villi together with fusion of shortened villi.
Exfoliation and necrosis of surface epithelial cells, flattening of
enterocytes and capillary thrombi at the tips of villi were also
observed. Submucosal areas were infiltrated with granulocytes,
lymphocytes and plasma cells (data not shown).
Immune response to GUS and PRRSV ORF5 elicited by
the helper-dependent expression system in swine
Groups of 1-week-old conventional swine were immunized
at days 7, 14 and 21 after birth with the helper virus plus the
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Fig. 6. Analysis of GUS gene transcription and expression from TGEV-derived minigenomes in ST cell monolayers. Confluent
monolayers of ST cells were inoculated with supernatant containing the helper virus PUR46-MAD (m.o.i. 5) and the
minigenome encoding the GUS gene (M39-GUS), and fixed 18 h p.i. with 4% paraformaldehyde. (A) ISH with a digoxigenin-
labelled probe specific for the 3« end of TGEV RNA. (B) ISH with a probe specific for GUS RNA. (C) Direct immunofluorescence
using FITC-labelled TGEV hyperimmune serum. (D) GUS enzymatic activity detected by histochemistry resulting in a Prussian
blue staining of GUS-expressing cells.
minigenome expressing GUS or ORF5 by the intranasal, oral
and intragastric routes. Animals were bled 7 days after the last
immunization and the sera were evaluated by ELISA for the
presence of antibodies to GUS or to a partially purified PRRSV,
depending on the antigen used.
Immunization with the TGEV-derived vector expressing
either GUS or PRRSV ORF5 elicited a significant immune
response both to the helper virus and to GUS (Fig. 9A 1 and
2) or to the helper virus and ORF5 (Fig. 9B 1, 2 and 3). The
antibody levels to the helper virus (TGEV) were higher than to
the heterologous gene in both cases. The response to GUS and
the PRRSV ORF5 was also studied by immunizing 4-week-old
newborn swine and was weaker than in 1-week-old animals
(results not shown).
The immune response to ORF5 was confirmed by studying
the response to a synthetic 18 amino acid peptide (NH
#
-142-
TNFIVDDRGRIHRWKSPI-159-COOH) derived from the
ORF5 of the PRRSV Olot91 strain (Plana-Dura! n et al., 1992).
This peptide was selected because it was previously shown
that the homologous peptide (NH
#
-143-CNFIVDDRGRVHR-
WKSPI-160-COOH) of the PRRSV Lelystad strain was
immunogenic (Meulenberg et al., 1995). To evaluate the
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Fig. 7. Replication of the helper virus in the intestine and lung of swine.
Growth kinetics of the helper virus isolated from the jejunum (A) and lungs
(B) of 2-day-old colostrum-deprived piglets oronasally and intragastrically
infected with a mixture containing the minigenome (M39-GUS) and 108
p.f.u. of the helper virus (PUR46-MAD). Animals were sacrificed on days
1, 2, 3 and 4 p.i. and subjected to necropsy. Columns indicate the mean
of virus titre obtained from six piglets inoculated with the helper
virus–minigenome mixture. Bars, standard error.
immune response to PRRSV, the 18-mer peptide was con-
jugated to KLH. A strong antibody response was detected
against the peptide in the absence of a response to the carrier
KLH. Interestingly, the swine antibodies raised against ORF5
neutralized the infection of MA-104 cells by 10# p.f.u. of
PRRSV, in contrast to sera collected from the same animals
before the immunization, which did not protect the cell
monolayer.
Discussion
Using a TGEV-derived expression system the production
of high levels of GUS and ORF5, involved in the protection
against PRRSV, has been achieved in tissue culture and in
swine. GUS expression lasted more than eight passages. It has
been shown that the minigenome was amplified for at least five
passages in cell culture and that, after passage four, deletion
mutants of the minigenome were generated. In addition, the
expression of GUS at cellular level in tissue culture and in vivo
has been reported. Using the TGEV-derived virus vector, the
induction of immune responses to GUS and the PRRSV ORF5
has been demonstrated in swine.
The helper-dependent expression system showed a limited
stability of the minigenome RNA during passage in cell
culture. Insertion of the PRRSV ORF5 and GUS genes in the
M39 minigenome led to the appearance of new minigenomes
that could easily be detected at passages four and five,
respectively. In contrast, the sgmRNAs were detected in low
amounts with the probes used in these experiments. Increase of
the probe size from 300 nt to around 10$ nt clearly revealed
the presence of the sgmRNAs (Alonso et al., 2002). In both
cases, protein expression levels were maintained for at least
eight passages. The stability of the TGEV-derived mini-
genomes was higher than that of the MHV-based helper
dependent expression system in which the expression of the
foreign gene is lost within the first three passages, probably
because of the lack of a packaging signal within the MHV
minigenomes (Lai & Cavanagh, 1997 ; Liao et al., 1995 ; Lin &
Lai, 1993 ; Zhang et al., 1997).
The stability of the expression systems is also conditioned
by the type of polymerases involved in minigenome amplifi-
cation and mRNA transcription (Agapov et al., 1998). The
expression system described in this report, based on TGEV-
derived minigenomes expressed under the control of the CMV
promoter, uses the eukaryotic RNA polymerase II to express
the minigenome, a process that takes place with an estimated
error frequency of 5‹10−’ (de Mercoyrol et al., 1992), which
is lower than the mutant accumulation frequency of 10−% to
10−& during the in vitro expression of minigenome RNAs
with T7 DNA-dependent RNA-polymerase (Boyer et al.,
1992 ; Sooknanan et al., 1994). In addition, the eukaryotic RNA
polymerase II has additional mechanisms to ensure even more
accurate transcription (Thomas et al., 1998). After transfection
of the in vitro-produced RNA, synthesis of mRNA by the viral
RNA-dependent RNA-polymerase should have an accumu-
lation of mutations with a relatively higher frequency of 10−$
to 10−% (de Mercoyrol et al., 1992 ; Ward et al., 1988). Overall,
an improvement in expression stability should be observed by
using expression systems initiated by DNA transfection, such
as those described in this report.
Using minigenomes derived from TGEV, expression was
highly dependent on the nature of the heterologous gene used.
Luciferase expression with TGEV minigenomes was reduced
to background levels and was lost after the fourth passage
(data not shown). In contrast, the expression of GUS was
higher (up to 8 lg per 10’ cells) and was observed for at least
eight passages in this and in a previous work (Alonso et al.,
2002). Similar results were observed using IBV minigenomes
(Stirrups et al., 2000).
The theoretical size of the insert accepted by the TGEV-
derived minigenomes is about 24 kb, since the size of the full-
length TGEV genome is 28–5 kb and the M39 has around 4 kb.
This cloning capacity would be the highest among virus
vectors with an RNA genome.
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Fig. 8. Expression of the GUS gene from TGEV-derived minigenomes in swine lungs. Cryostat sections of lung tissue from 2-
day-old piglets inoculated with the minigenome (M39-GUS) and 108 p.f.u. of helper virus (PUR46-MAD) by the oronasal route,
necropsied 2 days p.i. (A) ISH in bronchiolar epithelium and scattered pneumocytes with a digoxigenin-labelled probe specific
for TGEV RNA. (B) ISH, with a probe specific for GUS RNA. Pulmonary cells showing hybridization signals are indicated by
arrows. (C) Immunofluorescence, using an FITC-labelled TGEV-specific antiserum. (D) GUS histochemistry, singular cells show
enzymatic reactivity and Prussian blue staining. Bars indicate size (lm).
By studying the expression of GUS reporter gene in ST
cells infected with an m.o.i. of 5, it was observed that when
47% of the cells expressed virus vector RNA or protein, more
than one-quarter of them expressed the GUS RNA or protein.
The presence of cells negative for TGEV RNA was unexpected,
since the m.o.i. was 5. It is, in principle, possible that TGEV
replication is dependent on the cell cycle, since cells were not
synchronized.
Using TGEV-derived minigenomes, GUS was expressed in
lungs but not in the enteric tract, probably because the titres of
the helper virus in lungs were 40- to 10$-fold higher than in the
gut, and in the gut the minigenome and the helper virus were
not present within the same cell. The helper virus and GUS
RNAs were detected in more than 4–3% and 1–5% of the
cells, respectively. Interestingly, this reduced number of cells
expressing GUS (or even a lower one, since the immunized
piglets were conventional animals, i.e. non-colostrum-deprived
and, consequently, less susceptible to the virus than the
colostrum-deprived ones in which we determined the number
of infected cells) was sufficient to elicit an immune response to
GUS. This immune response was stronger against the helper
virus (TGEV) than against the heterologous antigens, par-
ticularly GUS, probably because the virus is a polymeric
antigen that is a better immunogen than the GUS. A similar
situation probably results after expression of the PRRSV
ORF5. The relatively strong immune response to the ORF5 is
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very promising, since this antigen is one of the major inducers
of protection against PRRSV (Pirzadeh & Dea, 1998 ; Plana-
Dura! n et al., 1997a, b). Interestingly, the PRRSV ORF5 18-mer
peptide selected was highly immunogenic as described for the
homologous peptide from the Lelystad strain of PRRSV
(Meulenberg et al., 1995).
In order to study the replication of the helper virus with the
minigenome, colostrum-deprived newborn animals were used
to potentiate the infection by the attenuated helper virus. This
resulted in an increased pathogenicity both in the lungs and in
the enteric tract. These side effects should be reduced to a
minimum in conventional (non-colostrum-deprived) piglets
since, even when they are infected at 2 days after birth, very
mild or no diarrhoea was induced after infection with the
PUR46-MAD strain of TGEV (Sa! nchez et al., 1999). These side
effects are even less when older animals are infected with
attenuated TGEV, such as the piglets used for the immunization
that were 1-week-old. In this case, we have shown an efficient
immune response to both GUS and PRRSV ORF5 in the
absence of clinical symptoms. The potential side effects caused
by the helper virus could be further prevented by using the
PTV strain of the same Purdue cluster of TGEV (Sa! nchez et al.,
1992), since this strain is respiratory and fully attenuated
(Sa! nchez et al., 1999) and has been shown to efficiently rescue
TGEV-derived minigenomes (J. M. Sa! nchez-Morgado, I. Sola,
J. Castilla & L. Enjuanes, unpublished results).
Overall, these results showed that foreign genes were
efficiently expressed in tissue culture by using TGEV-derived
minigenomes. Furthermore, the expression was specifically
targeted to tissues such as lung in swine, leading to the
induction of an immune response against an antigen such as the
PRRSV ORF5 involved in the protection against relevant virus
infections of livestock.
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Fig. 9. Antibody immune response against GUS or PRRSV elicited in swine
by TGEV-derived minigenomes. Swine were immunized using
minigenomes with the information for the GUS gene (A1 and A2) or for
the PRRSV ORF5 (B1, B2 and B3) and the helper virus (PUR46-MAD).
Antibody responses against TGEV (A1 and B1), GUS protein (A2),
partially purified PRRSV (B2) or a synthetic peptide from the ORF5 (see
Methods) conjugated to KLH (B3) were evaluated by ELISA in the serum
of immunized lactating piglets. The absorbance obtained with the serum
after the third inoculation (E) or the preimmune serum (+) is shown.
Binding of serum from immune animals to KLH is also shown (_). Results
show medium values from three experiments. Bars, standard deviation.
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